163 related articles for article (PubMed ID: 25461891)
1. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.
Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH
Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
[TBL] [Abstract][Full Text] [Related]
5. Isolation, synthesis and anti-hepatitis B virus evaluation of p-hydroxyacetophenone derivatives from Artemisia capillaris.
Zhao Y; Geng CA; Chen H; Ma YB; Huang XY; Cao TW; He K; Wang H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1509-14. PubMed ID: 25737008
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.
Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors.
Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X
Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252
[TBL] [Abstract][Full Text] [Related]
10. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs.
Zhang Y; Zhong H; Lv Z; Zhang M; Zhang T; Li Q; Li K
Eur J Med Chem; 2013 Apr; 62():158-67. PubMed ID: 23353737
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.
Jia W; Liu Y; Li W; Liu Y; Zhang D; Zhang P; Gong P
Bioorg Med Chem; 2009 Jul; 17(13):4569-74. PubMed ID: 19457674
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
16. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents.
Qiu J; Xu B; Gong Q; Pan W; Liu C; Huang Z; Gu X; Liang G
Chem Biodivers; 2016 Nov; 13(11):1584-1592. PubMed ID: 27451105
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents.
Guo RH; Zhang Q; Ma YB; Huang XY; Luo J; Wang LJ; Geng CA; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Bioorg Med Chem; 2011 Feb; 19(4):1400-8. PubMed ID: 21292495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]